Strong to the unprecedented clinical benefit offered by immune checkpoint blockade (Ipilimumab, Nivolumab, Pembrolizumab) cancer immunotherapy gained high interest in drug development.
To support your R&D program(s), we propose to explore and characterize the in vitro effect of your candidate compounds on human immune cells. To validate this approach, we characterized – on a 96-well throughput & live cell imaging platform – the effect of PDL1 blockade in our human immune cell proliferation assay, which shown a clear stimulatory effect (see Figure below).
Also, to strengthen the immune cell proliferation data, ancillary studies can be implemented such as the quantification of cytokines (IFNɣ, TNF) within the cell culture supernatant and flow cytometry analysis to analyze more in depth the possible MoA of your drug candidate.
Stimulatory effect of PDL1 on human PBMC proliferation. Real time detection of cell confluence (blue objects) using live-cell analysis platform reveals a strong enhancement of TCR stimulation with gold standard PDL1 immune checkpoint inhibitor. This results are confirmed by the increase in IFNɣ level.
You have noted very interesting details! ps decent web site.Raise your business
fantastic submit, very informative. I wonder why the other experts of this sector do not notice this. You must continue your writing. I’m sure, you’ve a huge readers’ base already!
I am genuinely thankful to the owner of this website for sharing his brilliant ideas. I can see how much you’ve helped everybody who comes across your page. By the way, here is my webpage 85N about Webdesign.
An interesting topic and I’m glad to come across your page where I found some helpful insights. Check out my website YW9 too, if you need additional resources about Internet Marketing.